As the world leader in in vitro allergy diagnostics, we supply seven out of ten allergy laboratory tests worldwide. ImmunoCAP offers everything from direct point-of-care tests to exact measurement of specific IgE antibody blood levels, as well as other important allergy risk markers. ImmunoCAP is one of the most important tools for truly understanding allergy, helping clinicians make sense of symptoms such as rhinitis, eczema, wheezing and asthma.
No wonder laboratories and physicians alike have come to rely on ImmunoCAP as their first choice for in vitro allergy testing.
High quality raw materials
To develop allergy tests, you have to have the allergens readily available. Over our nearly 40-year-long history, we have perfected our production techniques to ensure a constant supply of pure, stable and active allergens.
Over the years, ImmunoDiagnostics has acquired a unique competence in the large-scale cultivation of wild flowers, weeds and other plants, and we now produce the bulk of the pollenbased allergens we use in the 400-acre plantations surrounding our processing plant in Sweden. Our custom-built premises feature separate, aseptic and environmentally controlled buildings for different allergen types. Pure raw materials are forwarded to quality control and processing facilities at the test production plant in Uppsala.
For allergens not available in Sweden, we have secured supply from relevant geographical areas. In addition to our wide variety of pollens, we also produce a range of pure allergens from moulds, insect venoms, foods and animal epithelia.
Used within the field of molecular allergology, ImmunoCAP Allergen Components are single proteins purified from their natural source or produced via recombinant techniques.